MMP9 and breast carcinoma: Our results demonstrated that MMP-9 activities in MDA-MB-231 cells were reduced after actein treatment, suggesting that actein could inhibit breast cancer cell migration via reducing the degradation of ECM and hence cancer cell invasion.